170525 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
TEST METHOD ON RENAL DISEASES
#302Methods and compositions for wound treatment
#303Artificial antibody polypeptides
#304Type IV collagen-like immunoreactive peptide
#305Methods and compositions for diagnosing ankylosing spondylitis using biomarkers
#306METHODS FOR DIAGNOSIS AND PROGNOSIS OF CANCER
#307Immunoassay test strip for use in a diagnostic system
#308Methods to diagnose treat and prevent bone loss
#309Compositions for use in the treatment of chronic obstructive pulmonary diseases and asthma
#310Pathology biomarker assay
#311Methods for detecting oncofetal fibronectin
#312Non-Invasive Method for Assessing Liver Fibrosis Progression
#313DETECTING AND MONITORING LEFT VENTRICULAR HYPERTROPHY AND CONGESTIVE HEART FAILURE BY PROFILING BIOMARKERS
#314ENDOSTATIN AS A MARKER OF HEART FAILURE
#315System and Method for Determining Concentration of a Predetermined Osteoarthritis Biomarker in a Urine Sample
#316ASSESSMENT OF PROTEIN DEGRADATION BY MEASUREMENT OF ISOMERISED NEO-EPITOPE CONTAINING FRAGMENTS
#317ASSESSMENT OF SUBCHONDRAL BONE REMODELLING BY MEASURING CATHEPSIN K FRAGMENTS OF COLLAGEN TYPE II
#318Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use
#319PREDICTING CARDIOVASCULAR EVENTS AND RENAL FAILURE IN TYPE 1 DIABETICS
#320Methods of generating patterned soft substrates and uses thereof
#321BIOMARKER FOR OSTEOARTHRITIS AND/OR OTHER AGEING-RELATED DISEASES, AND USE THEREOF
#322Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof
#323Monitoring skin metabolism products for evaluating burn injury
#324Diagnosis of collagen IX destruction
#325Procollagen C-proteinase enhancer (PCPE) biomarker for bone formation
#326Nanoparticle and magnetic resonance imaging contrast agent
#327Ex vivo cell stimulation
#328Fibronectin-based binding molecules and uses thereof
#329EXTERNAL PREPARATION FOR SKIN CONTAINING FLAVANONE DERIVATIVE
#330Anti-human tenascin monoclonal antibody
#331Assessment of physiological conditions
#332Method for obtaning thin fibril collagen by contacting native collagen with an antibody
#333DETECTION OF FIBRIN AND FIBRINOGEN DEGRADATION PRODUCTS AND ASSOCIATED METHODS OF PRODUCTION AND USE FOR THE DETECTION AND MONITORING OF CANCER
#334Method for treating the Th2-mediated disease
#335Fibrosis biomarker assay
#336Lysyl oxidase-like 1 (LOXL1) and elastogenesis
#337METHODS OF VALIDATING CANDIDATE COMPOUNDS FOR USE IN TREATING COPD AND OTHER DISEASES
#338UNDERCARBOXYLATED/UNCARBOXYLATED OSTEOCALCIN INCREASES BETA-CELL PROLIFERATION, INSULIN SECRETION, INSULIN SENSITIVITY, GLUCOSE TOLERANCE AND DECREASES FAT MASS
#339Diagnosis and monitoring of renal failure using peptide biomarkers
#340Methods and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof
#341BIOMOLECULES
#342Blood biomarkers for bone fracture and cartilage injury
#343Artificial antibody polypeptides
#344Kits for biomarker detection and treatment selection
#345Methods for identifying or assaying for agents that increase beta-cell proliferation, insulin secretion, insulin sensitivity, glucose tolerance and decrease fat mass
#346Extracellular and membrane-associated prostate cancer markers
#347Method for Detecting Autoantibodies Formed in Rheumatoid Arthritis
#348Artificial antibody polypeptides
#349PREDICTION OF AN INDIVIDUAL'S RISK OF DEVELOPING RHEUMATOID ARTHRITIS
#350ED-B FIBRONECTIN AS STRATIFICATION MARKER FOR ANTI-TUMOR DRUGS
#351Specific binding sites in collagen for integrins and use thereof
#352Use of the ENDO-180 gene and polypeptide for diagnosis and treatment
#353DIAGNOSTIC BIOMARKERS FOR VASCULAR ANEURYSM
#354Type IV collagen-like immunoreactive peptide
#355Method for treating vascular disorders
#356Muscle lamin A/C interacting protein, gene encoding same, and uses therefor
#357Anticancer compounds and methods
#358Method for monitoring collagen type II degradation in cartilage
#359EXTERNAL PREPARATION FOR SKIN CONTAINING FLAVANONE DERIVATIVE
#360Lysyl oxidase-like 1 (LOXL1) and elastogenesis
#361Collagen VI and cancer
#362METHOD FOR DETERMINING PLASMINOGEN ACTIVATOR INHIBITOR
#363METHODS AND TOOLS FOR DETECTING COLLAGEN DEGRADATION
#364Compositions comprising modified collagen and uses therefor
#365Peptide for differentiating osteoarthritis from rheumatoid arthritis and non-disease conditions
#366Compositions and methods for inhibiting squamous cell carcinoma
#367Method for diagnosing diseases
#368Diagnosis of collagen IX destruction
#369Polypeptides, polynucleotides and uses thereof
#370Compositions and methods for inhibiting squamous cell carcinoma
#371ANTI-TENASCIN MONOCLONAL ANTIBODY IMMUNOASSAYS AND DIAGNOSTIC KITS
#372Cellular fibronectin as a diagnostic marker in cardiovascular disease and methods of use thereof
#373Monitoring of Vitamin K Nutritional Status
#374Methods and compositions for determining the efficacy of a treatment for ankylosing spondylitis using biomarkers
#375Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use
#376RECOMBINANT PLATELET COLLAGEN RECEPTOR GLYCOPROTEIN VI AND ITS PHARMACEUTICAL USE
#377Identification of compounds for inhibiting complexation of C-reactive protein with fibronectin
#378Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use
#379Treatment of infections utilizing antibodies that bind to fibronectin binding proteins
#380Method of treating wounds by enhancing expression of procollagen
#381Specific binding sites in collagen for integrins and use thereof
#382Methods of treating idiopathic pulmonary fibrosis
#383Novel screening method
#384Use of the endo-180 gene and polypeptide for diagnosis and treatment
#385Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass
#386Methods of screening for anti-inflammatory drugs and use thereof
#387Artificial antibody polypeptides
#388Methods of diagnosing and treating brain tumors
#389Agglomeration protein cascades, compositions and methods regarding the same
#390Non-invasive assessment of intra-amniotic environment
#391Artificial antibody polypeptides
#392Novel fibulin-like polypeptides
#393Method for identifying active anti-apoptosis compounds
#394Method of saying alastin digestion product and assay kit, method of detecting aortic dissection and detection kit
#395Anti-tenascin monoclonal antibody immunoassays and diagnostic kits
#396Fibulin-3 and uses thereof
#397Elastin prevents occlusion of body vessels by vascular smooth muscle cells
#398Methods for diagnosis and prognosis of cancer
#399Method for diagnosing obstructive sleep apnea
#400Lysyl oxidase-like 1 (LOXL1) and elastogenesis
#401Detection of oncofetal fibronectin for selection of concepti
#402Oncofetal fibronectin as a marker for pregnancy-related indications
#403Oncofetal fibronectin as a marker for health and disease
#404Methods for detecting oncofetal fibronectin
#405Samples for detection of oncofetal fibronectin and uses thereof
#406Point of care diagnostic systems
#407Compositions and methods for inhibiting squamous cell carcinoma
#408Point of care diagnostic systems
#409Serum biomarkers for Chagas disease
#410Method for monitoring treatment with a parathyroid hormone
#411Methods and tools for detecting collagen degradation
#412Method for immunohistochemical detection of collagen in a tissue sample
#413Receptor of the EDb-fibronectin domains
#414Support with crosslinked marine collagen for tissue engineering and manufacture of biomaterials
#415Lysyl oxidase-like 1 (LOXL1) and elastogenesis
#416Method for treating Th2-mediated disease
#417Method for monitoring collagen type II degradation in cartilage
#418Method for measuring the amount of betaig-h3 protein and diagnostic kit using the same
#419Methods and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof
#420Method of measurement of protease and thin membranes used for said method
#421Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
#422Fibronectin binding protein compositions and methods of use
#423Fibronectin variants and screening methods
#424Anti-human tenascin monoclonal antibody
#425Receptor of the EDb-fibronectin domains
#426Diagnosis of clinical infection of a wound
#427Laminin chains: diagnostic and therapeutic use
#428Methods and compositions for the assessment of polymer assembly
#429Methods and compositions for diagnosing and treating disorders involving angiogenesis
#430Collagenase assay
#431System and method for bone loss assay